
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
Cognito Therapeutics is a pioneer in non-invasive neuromodulation to treat neurodegenerative diseases and improve human cognitive performance. The company has completed multiple clinical studies demonstrating its investigational therapeutic has the potential to safely slow or stop cognitive decline and loss of brain volume in Alzheimers disease. Cognito has received FDA Breakthrough Device Designation for the treatment of Alzheimers disease and expects to start pivotal studies in 2022. The companys technology was based on pioneering optogenetics research by scientific co-founders Professors Li-Huei Tsai and Ed Boyden at MIT
Cognito therapeutics, inc operates in the Medical equipment manufacturing industry.
Cognito therapeutics, inc's revenue is 11m - 100m
Cognito therapeutics, inc has 51 - 200 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.